Search results for "arki"

showing 10 items of 1015 documents

Music therapy in Parkinson's disease

2014

Parkinson's Diseasemusic therapymusiikkiParkinsonin tautimusiikkiterapiaTapaustutkimushermoston tauditelderlyikääntyneet
researchProduct

Linguistic, psychometric validation and diagnostic ability assessment of an Italian version of a 19-item wearing-off questionnaire for wearing-off de…

2012

Parkinson's disease wearing off motor fluctuations
researchProduct

Urinary dysfunction in Parkinson’s disease patients

2016

Background: Autonomic nervous system dysfunction that affects 70–80% of Parkinson’s disease (PD) patients, causes significant morbidity and it is correlated with poor quality of life. Objective: We assessed in a consecutive series of PD patients frequency of autonomic symptoms by means of the Scale for Outcomes for Parkinson’s disease AUTonomic (SCOPA-AUT) and we correlated it with the results of noninvasive urological studies (nUS). Methods: PD patients with known conditions that might have influenced urinary function were excluded. Clinical assessment of PD patients included the H&Y staging, UPDRS, BDI, NPI, PDQ- 39, PDSS, ESS, and the SCOPA-AUT scale. nUS consisted of uroflowmetry an…

Parkinson's disease autonomic nervous systemSettore MED/26 - Neurologia
researchProduct

Sleep disturbances and dysautonomic dysfunction are associated in patients with Parkinson’s disease

2012

Parkinson's disease dysautonomic dysfunction sleep disturbancesSettore MED/26 - Neurologia
researchProduct

Facts and controversies regarding oral health in Parkinson's disease: A case-control study in Spanish patients.

2022

Background: Parkinson's disease (PD) is one of the leading neurological disorders, affecting more than 6 million people worldwide. These patients present motor and non-motor symptoms, including oral pathology. The objective of this research is to determine the oral health of patients diagnosed with PD, in order to stablish a specific preventive oral health programme. Material and methods: Case-control study on 104 PD and 106 control patients. The pre-designed clinical protocol included a complete oral examination on general aspects, standardised epidemiological index for caries, periodontal disease and edentulism, analysis of oral hygiene, presence of mucous/ salivary/ functional disorder, …

Parkinson's disease oral health dysgeusia dysphagia droolingParkinson's disease (PD)dysphagiadrooling.cross-sectional studyOral HealthParkinson DiseaseSialorrheaOral HygieneOtorhinolaryngologyCase-Control StudiesHumansSurgerydysgeusiaoral disordersperiodontitisGeneral DentistryUNESCO:CIENCIAS MÉDICAScariesMedicina oral, patologia oral y cirugia bucal
researchProduct

Hypothesis: can N-acetylcysteine be beneficial in Parkinson's disease?

1999

Based on the finding of decreased mitochondrial complex I activity in the substantia nigra of patients with Parkinson's disease, we propose that the consequent reduction of ATP synthesis and increased generation of reactive oxygen species may be a possible cause of nigrostriatal cell death. Since sulfhydryl groups are essential in oxidative phosphorylation, thiolic antioxidants may contribute to the preservation of these proteins against oxidative damage. In the present paper, we hypothesize that treatment with a sulfur-containing antioxidant such as N-acetylcysteine may provide a new neuroprotective therapeutic strategy for Parkinson's disease.

Parkinson's diseaseAntioxidantmedicine.medical_treatmentModels NeurologicalSubstantia nigraOxidative phosphorylationPharmacologyBiologyMitochondrionNeuroprotectionGeneral Biochemistry Genetics and Molecular BiologyOxidative PhosphorylationAcetylcysteineAdenosine TriphosphatemedicineNAD(P)H Dehydrogenase (Quinone)HumansGeneral Pharmacology Toxicology and Pharmaceuticschemistry.chemical_classificationReactive oxygen speciesParkinson DiseaseGeneral Medicinemedicine.diseaseCorpus StriatumAcetylcysteineMitochondriaSubstantia NigraNeuroprotective AgentschemistryReactive Oxygen SpeciesNeurosciencemedicine.drugLife sciences
researchProduct

Parkinson's disease and cancer: insights for pathogenesis from epidemiology .

2009

Epidemiological evidence suggests a reduced incidence of many common types of cancers in individuals with Parkinson's disease (PD). Parkinson's disease and cancer are two diseases that result from an excessive signaling by one of two forces driving cells to opposite directions. PD results from the excessive death of dopaminergic neurons in the substantia nigra pars compacta (SNc) in the brain, while uncontrolled growth is the key property of cancer. Parkinson's disease is a complex disorder, probably due in most of the cases to the interaction of environment and genes. Many genes responsible for familial forms of PD are supposed to have a supportive role in regulating or maintaining the cel…

Parkinson's diseaseCell Deathbusiness.industryPars compactaGeneral NeuroscienceIncidenceDopaminergicCancerSubstantia nigraParkinson DiseaseDiseaseCell cyclemedicine.disease_causemedicine.diseaseGeneral Biochemistry Genetics and Molecular BiologySubstantia NigraHistory and Philosophy of ScienceRisk FactorsNeoplasmsMedicineHumansbusinessCarcinogenesisNeuroscienceAnnals of the New York Academy of Sciences
researchProduct

Small Extracellular Vesicles Secreted by Region-specific Astrocytes Ameliorate the Mitochondrial Function in a Cellular Model of Parkinson’s Disease

2021

AbstractExtracellular vesicles (EVs) are emerging as powerful players in cell-to-cell communication both in health and diseased brain. In Parkinson’s disease (PD) – characterized by selective dopaminergic (DAergic) neuron death in ventral midbrain (VMB) and degeneration of DAergic terminals in striatum (STR) – astrocytes (AS) exert dual harmful/protective functions. When activated by chemokine CCL3, AS promote a robust DAergic neuroprotection both in cellular and pre-clinical models of PD, with mechanisms not fully elucidated. Here we used a combination of techniques to characterize AS-EVs derived from VMB and STR, and investigated their potential to exert neuroprotection. First, we show th…

Parkinson's diseaseChemistryDopaminergicmedicineSecretionStriatumCellular modelmedicine.disease_causeNeuron deathmedicine.diseaseNeuroprotectionOxidative stressCell biology
researchProduct

Optimization of the KNN Supervised Classification Algorithm as a Support Tool for the Implantation of Deep Brain Stimulators in Patients with Parkins…

2019

Deep Brain Stimulation (DBS) of the Subthalamic Nuclei (STN) is the most used surgical treatment to improve motor skills in patients with Parkinson&rsquo

Parkinson's diseaseDeep brain stimulationmicroelectrode registers-MERComputer sciencemedicine.medical_treatmentGeneral Physics and Astronomylcsh:AstrophysicsFeature selection02 engineering and technologybehavioral disciplines and activitiesArticlePharmacological treatment03 medical and health sciencesNeurologiafeature selection0302 clinical medicinedeep brain stimulation-DBSClinical supportlcsh:QB460-4660202 electrical engineering electronic engineering information engineeringmedicineIn patientlcsh:ScienceMotor skillK-nearest neighbour-KNN algorithmmedicine.diseaseBrain stimulatorslcsh:QC1-999nervous system diseasessurgical procedures operativenervous systemParkinson’s diseaselcsh:Q020201 artificial intelligence & image processingEnginyeria biomèdicatherapeuticsAlgorithmlcsh:Physics030217 neurology & neurosurgery
researchProduct

Neurofibrillary tangles and neuropil threads as a cause of dementia in Parkinson’s disease

1997

Alzheimer’s disease (AD) and Parkinson’s disease (PD) are the most common age-related degenerative disorders of the human brain. Both diseases involve multiple neuronal systems and are the consequences of cytoskeletal abnormalities. In AD susceptible neurons produce neurofibrillary changes, while in Parkinson’s disease, they develop Lewy bodies. In AD six developmental stages can be distinguished on account of the predictable manner in which the neurofibrillary changes spread across the cerebral cortex. During the course of PD numerous limbic determined parts of the brain undergo specific lesions regulating endocrine and autonomic functions. In general, the extranigral destructions are in t…

Parkinson's diseaseDegenerative Disorderbusiness.industryDiseaseHuman brainEntorhinal cortexmedicine.diseaseNeuropil threadmedicine.anatomical_structureCerebral cortexmedicineDementiabusinessNeuroscience
researchProduct